The advancements in nanotechnology have opened up novel possibilities for drug delivery in cancer treatment. Among these, carbon-based nanomaterials have shown significant promise due to their capacity to carry multiple anticancer drugs. In particular, graphene oxide (GO) and its derivatives have been extensively studied and utilized as effective carriers for cancer drug delivery, due to their high drug-loading capability, large surface area, and ease of functionalization. This mini-review aims to provide recent evidence highlighting the important role of GO and its derivatives in cancer diagnosis and therapy.
No takes yet. Share an insight, caveat, or question.
Das et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: